ArticleBMC cancer2023

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.

Huanyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.